Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Kaiser

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Frontiers in Immunology|October 30, 2023
Combining CSPG4-CAR and CD20-CCR for treatment of metastatic melanomaKarin Teppert, Nora Winter, Vera Herbel, et al.
Viruses|October 27, 2022
Adapter-Mediated Transduction with Lentiviral Vectors: A Novel Tool for Cell-Type-Specific Gene TransferNicole Cordes, Nora Winter, Carolin Kolbe, et al.
Journal for Immunotherapy of Cancer|May 19, 2017
A tandem CD19/CD20 CAR lentiviral vector drives on-target and off-target antigen modulation in leukemia cell linesDina Schneider, Ying Xiong, Darong Wu, et al.
Cancer Immunology, Immunotherapy : CII|March 30, 2010
RNA interference targeting programmed death receptor-1 improves immune functions of tumor-specific T cellsLisa Borkner, Andrew Kaiser, Willeke van de Kasteele, et al.
The Journal of Clinical Investigation|February 3, 2007
Hematopoietic stem cells promote the expansion and function of adoptively transferred antitumor CD8 T cellsClaudia Wrzesinski, Chrystal M Paulos, Luca Gattinoni, et al.
Oncoimmunology|January 18, 2021
Adapter chimeric antigen receptor (AdCAR)-engineered NK-92 cells: an off-the-shelf cellular therapeutic for universal tumor targetingStefan Grote, Joerg Mittelstaet, Caroline Baden, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 3, 2009
Increased intensity lymphodepletion enhances tumor treatment efficacy of adoptively transferred tumor-specific T cellsClaudia Wrzesinski, Chrystal M Paulos, Andrew Kaiser, et al.
Frontiers in Immunology|February 23, 2018
CD137+CD154- Expression As a Regulatory T Cell (Treg)-Specific Activation Signature for Identification and Sorting of Stable Human Tregs from <i>In Vitro</i> Expansion CulturesAnna Nowak, Dominik Lock, Petra Bacher, et al.
Blood|May 28, 2009
Type 17 CD8+ T cells display enhanced antitumor immunityChristian S Hinrichs, Andrew Kaiser, Chrystal M Paulos, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2008
Requirements for effective antitumor responses of TCR transduced T cellsMoniek A de Witte, Annelies Jorritsma, Andrew Kaiser, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Frontiers in Immunology|October 30, 2023
Combining CSPG4-CAR and CD20-CCR for treatment of metastatic melanomaKarin Teppert, Nora Winter, Vera Herbel, et al.
Viruses|October 27, 2022
Adapter-Mediated Transduction with Lentiviral Vectors: A Novel Tool for Cell-Type-Specific Gene TransferNicole Cordes, Nora Winter, Carolin Kolbe, et al.
Journal for Immunotherapy of Cancer|May 19, 2017
A tandem CD19/CD20 CAR lentiviral vector drives on-target and off-target antigen modulation in leukemia cell linesDina Schneider, Ying Xiong, Darong Wu, et al.
Cancer Immunology, Immunotherapy : CII|March 30, 2010
RNA interference targeting programmed death receptor-1 improves immune functions of tumor-specific T cellsLisa Borkner, Andrew Kaiser, Willeke van de Kasteele, et al.
The Journal of Clinical Investigation|February 3, 2007
Hematopoietic stem cells promote the expansion and function of adoptively transferred antitumor CD8 T cellsClaudia Wrzesinski, Chrystal M Paulos, Luca Gattinoni, et al.
Oncoimmunology|January 18, 2021
Adapter chimeric antigen receptor (AdCAR)-engineered NK-92 cells: an off-the-shelf cellular therapeutic for universal tumor targetingStefan Grote, Joerg Mittelstaet, Caroline Baden, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 3, 2009
Increased intensity lymphodepletion enhances tumor treatment efficacy of adoptively transferred tumor-specific T cellsClaudia Wrzesinski, Chrystal M Paulos, Andrew Kaiser, et al.
Frontiers in Immunology|February 23, 2018
CD137+CD154- Expression As a Regulatory T Cell (Treg)-Specific Activation Signature for Identification and Sorting of Stable Human Tregs from <i>In Vitro</i> Expansion CulturesAnna Nowak, Dominik Lock, Petra Bacher, et al.
Blood|May 28, 2009
Type 17 CD8+ T cells display enhanced antitumor immunityChristian S Hinrichs, Andrew Kaiser, Chrystal M Paulos, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2008
Requirements for effective antitumor responses of TCR transduced T cellsMoniek A de Witte, Annelies Jorritsma, Andrew Kaiser, et al.
Pageof 4